Quotes 5-day view Delayed Nyse
02/23/2021
02/24/2021
02/25/2021
02/26/2021
03/01/2021
Date
594.48(c)
594.74(c)
582.45(c)
584.5(c)
597.3
Last
279 565
197 797
264 731
242 319
157 412
Volume
-1.50%
+0.04%
-2.07%
+0.35%
+2.19%
Change
Sales 2021
2 615 M
-
-
Net income 2021
358 M
-
-
Net Debt 2021
-
-
-
P/E ratio 2021
49,3x
Yield 2021
-
Sales 2022
2 738 M
-
-
Net income 2022
-
-
-
Net Debt 2022
-
-
-
P/E ratio 2022
-
Yield 2022
-
Capitalization
17 526 M
17 526 M
-
Capi. / Sales 2021
6,70x
Capi. / Sales 2022
6,40x
Nbr of Employees
8 000
Free-Float
70,9%
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and...
All news about BIO-RAD LABORATORIES, INC.
News in other languages on BIO-RAD LABORATORIES, INC.
Analyst Recommendations on BIO-RAD LABORATORIES, INC.
Chart BIO-RAD LABORATORIES, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends BIO-RAD LABORATORIES, INC.
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
4
Average target price
655,00 $
Last Close Price
584,50 $
Spread / Highest target
30,0%
Spread / Average Target
12,1%
Spread / Lowest Target
-34,1%
Please enable JavaScript in your browser's settings to use dynamic charts.